These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16632476)
21. Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Issa AY; Volate SR; Muga SJ; Nitcheva D; Smith T; Wargovich MJ Carcinogenesis; 2007 Sep; 28(9):1978-84. PubMed ID: 17638923 [TBL] [Abstract][Full Text] [Related]
22. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Ilantzis C; DeMarte L; Screaton RA; Stanners CP Neoplasia; 2002; 4(2):151-63. PubMed ID: 11896570 [TBL] [Abstract][Full Text] [Related]
23. Genome-wide association and fine mapping of genetic loci predisposing to colon carcinogenesis in mice. Liu P; Lu Y; Liu H; Wen W; Jia D; Wang Y; You M Mol Cancer Res; 2012 Jan; 10(1):66-74. PubMed ID: 22127497 [TBL] [Abstract][Full Text] [Related]
24. Lack of enhancing effects of degraded lambda-carrageenan on the development of beta-catenin-accumulated crypts in male DBA/2J mice initiated with azoxymethane. Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Kuno T; Hirose Y; Hara A; Mori H Cancer Lett; 2006 Jul; 238(1):69-75. PubMed ID: 16046055 [TBL] [Abstract][Full Text] [Related]
25. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Neufert C; Becker C; Neurath MF Nat Protoc; 2007; 2(8):1998-2004. PubMed ID: 17703211 [TBL] [Abstract][Full Text] [Related]
26. The effect of kefir on glutathione (GSH), malondialdehyde (MDA) and nitric oxide (NO) levels in mice with colonic abnormal crypt formation (ACF) induced by azoxymethane (AOM). Cenesiz S; Devrim AK; Kamber U; Sozmen M Dtsch Tierarztl Wochenschr; 2008 Jan; 115(1):15-9. PubMed ID: 18265753 [TBL] [Abstract][Full Text] [Related]
27. Azoxymethane-induced pre-adipocyte factor 1 (Pref-1) functions as a differentiation inhibitor in colonic epithelial cells. Dong M; Guda K; Nambiar PR; Nakanishi M; Lichtler AC; Nishikawa M; Giardina C; Rosenberg DW Carcinogenesis; 2004 Nov; 25(11):2239-46. PubMed ID: 15297369 [TBL] [Abstract][Full Text] [Related]
28. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice. Hu Y; Le Leu RK; Belobrajdic D; Young GP Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704 [TBL] [Abstract][Full Text] [Related]
29. Identification and comparison of residues critical for cell-adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8. Kuroki M; Abe H; Imakiirei T; Liao S; Uchida H; Yamauchi Y; Oikawa S; Kuroki M J Leukoc Biol; 2001 Oct; 70(4):543-50. PubMed ID: 11590190 [TBL] [Abstract][Full Text] [Related]
30. Contribution of intestinal epithelial cells to innate immunity of the human gut--studies on polarized monolayers of colon carcinoma cells. Ou G; Baranov V; Lundmark E; Hammarström S; Hammarström ML Scand J Immunol; 2009 Feb; 69(2):150-61. PubMed ID: 19170965 [TBL] [Abstract][Full Text] [Related]
31. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044 [TBL] [Abstract][Full Text] [Related]
33. Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model. Alain T; Wong JF; Endersby R; Urbanski SJ; Lee PW; Muruve DA; Johnston RN; Forsyth PA; Beck PL Cancer Gene Ther; 2007 Oct; 14(10):867-72. PubMed ID: 17627293 [TBL] [Abstract][Full Text] [Related]
34. Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model. Doi K; Hagihara A; Wei M; Yunoki T; Fukushima S; Wanibuchi H Oncology; 2007; 73(3-4):252-60. PubMed ID: 18424890 [TBL] [Abstract][Full Text] [Related]
35. Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism. Riehl TE; George RJ; Sturmoski MA; May R; Dieckgraefe B; Anant S; Houchen CW Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1062-70. PubMed ID: 17038629 [TBL] [Abstract][Full Text] [Related]
36. High concentration of deoxycholic acid abrogates in vitro transformation of IEC6 intestinal cells by azoxymethane. Sasaki T; Shimura H; Sasahira T; Fujii K; Kuniyasu H J Exp Clin Cancer Res; 2005 Dec; 24(4):625-31. PubMed ID: 16471326 [TBL] [Abstract][Full Text] [Related]
37. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
38. Expression analysis of the group IIA secretory phospholipase A(2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis. Papanikolaou A; Wang QS; Mulherkar R; Bolt A; Rosenberg DW Carcinogenesis; 2000 Feb; 21(2):133-8. PubMed ID: 10657948 [TBL] [Abstract][Full Text] [Related]
39. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma tempers the expression of carcinoembryonic antigen family molecules in human colon cells: a possible role in innate mucosal defence. Fahlgren A; Baranov V; Frängsmyr L; Zoubir F; Hammarström ML; Hammarström S Scand J Immunol; 2003 Dec; 58(6):628-41. PubMed ID: 14636419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]